National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 6) (No. PB 58 of 2011)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
PB 58 of 2011
National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 6)1
National Health Act 1953
I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under section 85B of the National Health Act 1953.
Dated 26 August 2011
 
 
 
 
 
 
 
FELICITY McNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 6).
            (2)        This Instrument may also be cited as PB 58 of 2011.
2          Commencement
            This Instrument commences on 1 September 2011.  
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1]       Paragraph 7(1)(c)
omit:
Medicare Australia CEO
substitute:
Chief Executive Medicare
[2]       Schedule 1, entry for Alendronic Acid in the form Tablet 70 mg (as alendronate sodium)
omit from the column headed “Claimed Price”:                          28.46     substitute:             29.10
[3]       Schedule 1, after entry for Alendronic Acid
insert:
Alendronic acid with colecalciferol
Tablet equivalent to 70 mg (as alendronate sodium) with 140 micrograms colecalciferol
Oral
Fosamax Plus 70 mg/140 mcg
4
34.24
36.74
[4]       Schedule 1, omit entry for Bromocriptine
[5]       Schedule 1, entry for Doxycycline
substitute:
Doxycycline
Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
Oral
Doryx
7
1.69
2.64

 
 
Oral
Doryx
21
5.04
6.76

 
Tablet 50 mg (as hydrochloride)
Oral
Vibra-Tabs
25
3.01
4.05

 
Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
Oral
Doryx
25
3.01
4.09

[6]       Schedule 1, entry for Mirtazapine in the form Tablet 30 mg
omit from the column headed “Claimed Price”:                          19.84     substitute:             20.32
 
[7]       Schedule 1, entry for Mirtazapine in the form Tablet 45 mg
omit from the column headed “Claimed Price”:                          31.57     substitute:             32.12
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.

Related Laws